140 related articles for article (PubMed ID: 23731924)
1. Impairment of platelet retention rate in patients with severe aortic valve stenosis.
Takahashi N; Tanabe K; Yoshitomi H; Adachi T; Ito S; Sugamori T; Endo A; Ishibashi Y; Oda T
J Cardiol; 2013 Sep; 62(3):171-5. PubMed ID: 23731924
[TBL] [Abstract][Full Text] [Related]
2. Acquired von Willebrand syndrome in aortic stenosis.
Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
[TBL] [Abstract][Full Text] [Related]
3. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
4. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis.
Yoshida K; Tobe S; Kawata M; Yamaguchi M
Ann Thorac Surg; 2006 Feb; 81(2):490-4. PubMed ID: 16427837
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
6. No excess surgical blood loss in patients with acquired type 2A von Willebrand disease.
Mikkelsen MM; Fenger-Eriksen C; Johnsen SP; Christensen TD; Sørensen B
Scand Cardiovasc J; 2011 Apr; 45(2):120-6. PubMed ID: 21189095
[TBL] [Abstract][Full Text] [Related]
7. Effect of transcutaneous aortic valve implantation on the Heyde's syndrome.
Benton SM; Kumar A; Crenshaw M; Fredi JL
Am J Cardiol; 2014 Sep; 114(6):953-4. PubMed ID: 25208564
[TBL] [Abstract][Full Text] [Related]
8. Prevalent platelet dysfunction in patients with aortic valve disease.
Prohaska W; Zittermann A; Lüth JU; Inoue K; Köster-Eiserfunke W; Baller D; Körfer R; Kleesiek K
J Heart Valve Dis; 2008 Sep; 17(5):542-7. PubMed ID: 18980088
[TBL] [Abstract][Full Text] [Related]
9. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
[TBL] [Abstract][Full Text] [Related]
10. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
Casonato A; Galletta E; Cella G; Barbon G; Daidone V
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
[TBL] [Abstract][Full Text] [Related]
13. Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis.
Undas A; Windyga J; Bykowska K; Dimitrow PP; Stepien E; Sadowski J
Thromb Haemost; 2009 Apr; 101(4):773-4. PubMed ID: 19350125
[No Abstract] [Full Text] [Related]
14. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion.
Steinlechner B; Zeidler P; Base E; Birkenberg B; Ankersmit HJ; Spannagl M; Quehenberger P; Hiesmayr M; Jilma B
Ann Thorac Surg; 2011 May; 91(5):1420-6. PubMed ID: 21439546
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
Van Belle E; Rauch A; Vincentelli A; Jeanpierre E; Legendre P; Juthier F; Hurt C; Banfi C; Rousse N; Godier A; Caron C; Elkalioubie A; Corseaux D; Dupont A; Zawadzki C; Delhaye C; Mouquet F; Schurtz G; Deplanque D; Chinetti G; Staels B; Goudemand J; Jude B; Lenting PJ; Susen S
Circ Res; 2015 Mar; 116(7):1193-201. PubMed ID: 25670067
[TBL] [Abstract][Full Text] [Related]
16. Persistent anemia in otherwise asymptomatic severe aortic stenosis: a possible indication for valve replacement?
Leibovitz E; Harpaz D; Elly I; Klepfish A; Gavish D
Isr Med Assoc J; 2004 Jul; 6(7):400-2. PubMed ID: 15274529
[TBL] [Abstract][Full Text] [Related]
17. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Heyde's syndrome by abnormal closure times despite normal von Willebrand's activity.
D'Souza PM; Blostein MD
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):622-3. PubMed ID: 21760480
[TBL] [Abstract][Full Text] [Related]
19. Aortic stenosis and acquired von Willebrand disease: lack of association.
Carrasco E; López R; Rattalino M; Lema G; Pereira J; Canessa R; Zalaquett R; Carvajal C; Carrasco P
J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):615-8. PubMed ID: 21493091
[TBL] [Abstract][Full Text] [Related]
20. Successful aortic valve replacement for Heyde syndrome with confirmed hematologic recovery.
Morishima A; Marui A; Shimamoto T; Saji Y; Tambara K; Nishina T; Komeda M
Ann Thorac Surg; 2007 Jan; 83(1):287-8. PubMed ID: 17184682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]